Literature DB >> 34229603

Palmo-plantar hyperkeratosis associated with HTLV-1 infection: a case report.

Elías Quintero-Muñoz1, Daniel Martin Arsanios2, María Fernanda Estupiñán Beltrán3, Juan David Vera4, Catalina Palacio Giraldo1, Omar Velandia4, Carlos Mauricio Calderon4.   

Abstract

BACKGROUND: Palmoplantar hyperkeratosis is a cutaneous manifestation that had not been clearly associated with infection by the human T-cell lymphotropic virus, which is a retrovirus that in most cases does not develop clinical pathologies and its symptoms may be undetected. The skin is one of the most affected organs, however until now only seborrheic dermatitis, xerosis/ichthyosis and infective dermatitis associated with HTLV-1 have been described as cutaneous clinical manifestations of this disease. CASE
PRESENTATION: We present the case of a 36-year-old male patient with serologically documented HTLV-1 infection, who presented symptoms of diarrhea, malabsorption due to Strongyloides stercoralis, and in whom a physical examination revealed an association with generalized xerosis and palmoplantar keratoderma confirmed by skin biopsy. Other infectious etiologies and malignancy were ruled out. This clinical manifestation was managed with dermal hydration, and skin care which improved the thickened skin and make it less noticeable.
CONCLUSIONS: According to our experience, this is the first reported case of palmoplantar keratoderma associated with a human lymphotropic virus infection. This is a skin manifestation that has not been confirmed in conjunction with HTLV-I before. This implies that palmoplantar keratoderma is a new clinical manifestation of this infection, that should be considered in the initial approach of patients in endemic areas with these dermatological characteristics.

Entities:  

Keywords:  Case report; HTLV; Malabsortive diarrhea; Palmoplantar keratoderma; Strongyloides stercoralis

Year:  2021        PMID: 34229603     DOI: 10.1186/s12879-021-06334-x

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  13 in total

1.  Dermatological findings of human T lymphotropic virus type 1 (HTLV-I)-associated myelopathy/tropical spastic paraparesis.

Authors:  Maria E R Lenzi; Tullia Cuzzi-Maya; André L A Oliveira; Maria J Andrada-Serpa; Abelardo Q-C Araújo
Journal:  Clin Infect Dis       Date:  2003-01-30       Impact factor: 9.079

2.  Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I).

Authors:  Lorena Dantas; Eduardo Netto; Marshall J Glesby; Edgar M Carvalho; Paulo Machado
Journal:  Int J Dermatol       Date:  2013-09-30       Impact factor: 2.736

3.  Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil.

Authors:  Vandack Nobre; Antônio Carlos Guedes; Marina Lobato Martins; Edel Figueiredo Barbosa-Stancioli; José Carlos Serufo; Fernando Augusto Proietti; João Gabriel Ribas; Cibele Eponina Sanchez Ferreira; José Roberto Lambertucci
Journal:  Clin Infect Dis       Date:  2006-10-16       Impact factor: 9.079

4.  [Cutaneous manifestations detected in human T cell lymphotropic virus type 1 infected Chilean blood donors].

Authors:  Isidora García-Huidobro; Consuelo Cárdenas; Monserrat Molgó; Sergio González
Journal:  Rev Med Chil       Date:  2014-07       Impact factor: 0.553

Review 5.  Cutaneous manifestations associated with HTLV-1 infection.

Authors:  Achiléa L Bittencourt; Maria de Fátima Paim de Oliveira
Journal:  Int J Dermatol       Date:  2010-10       Impact factor: 2.736

Review 6.  Human T-lymphotropic virus 1 (HTLV-1) infection--dermatological implications.

Authors:  Masahiro Amano; Mitsuru Setoyama; Annika Grant; Francisco A Kerdel
Journal:  Int J Dermatol       Date:  2011-08       Impact factor: 2.736

Review 7.  Acquired palmoplantar keratoderma.

Authors:  Shaily Patel; Matthew Zirwas; Joseph C English
Journal:  Am J Clin Dermatol       Date:  2007       Impact factor: 7.403

8.  Prevalence of human T-cell lymphotropic virus I and II in Colombian blood donors, 2001-2014: Implications for transfusion safety.

Authors:  María Isabel Bermúdez-Forero; Maritza Berrío-Pérez; Andrea Magally Herrera-Hernández; Magda Juliana Rodríguez-Rodríguez; Sandra García-Blanco; Guillermo Orjuela-Falla; Mauricio Beltrán
Journal:  Biomedica       Date:  2016-05-04       Impact factor: 0.935

9.  Successful treatment of adult T-cell leukemia/lymphoma with MACOP-B, M-FEPA and VEPP-B combination chemotherapy.

Authors:  T Nagatani; M Miyazawa; T Matsuzaki; G Iemoto; S Kim; N Baba; K Miyakawa; H Miyamoto; H Nakajima; Y Hirai
Journal:  J Dermatol       Date:  1993-10       Impact factor: 4.005

10.  Clinical manifestations associated with HTLV type I infection: a cross-sectional study.

Authors:  Marina F Caskey; Daniel J Morgan; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Glória O Orge; Maria J Travassos; Yolanda Barrón; Edgar M Carvalho; Marshall J Glesby
Journal:  AIDS Res Hum Retroviruses       Date:  2007-03       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.